<DOC>
	<DOCNO>NCT00131586</DOCNO>
	<brief_summary>Cisplatin widely use anti-tumor agent treatment testicular ovarian cancer . Carboplatin use extensively small cell , non small cell lung cancer ovarian cancer . Oxaliplatin recently approve United States ( US ) treatment colorectal cancer . A large portion ( range 65 % 98 % ) cisplatin blood plasma bound protein within day intravenous administration . The binding cisplatin analogue proteins enzyme generally believe cause several severe side effect ototoxicity nephrotoxicity . The interaction platinum base chemotherapy drug protein propose play important role drug activity toxicity . Therefore , good understand molecular mechanism platinum-protein interaction may impact optimization strategy treatment . The objective develop novel approach technique provide detailed mechanistic , kinetic high-resolution structural information bind platinum analogue blood protein , improve treatment efficacy reduce side effect .</brief_summary>
	<brief_title>Cisplatin , Carboplatin , Oxaliplatin Interactions With Plasma Proteins</brief_title>
	<detailed_description>Cisplatin , cis- [ Pt ( NH3 ) 2Cl2 ] , widely use antitumor agent treatment testicular ovarian cancer . Carboplatin use extensively small cell , non small cell lung cancer ovarian cancer . Oxaliplatin recently approve US treatment colorectal cancer . All analogue administer intravenous injection , within one day , 65-98 % platinum blood plasma bound protein . Binding cisplatin protein reduce urinary excretion platinum , cause deposition platinum tissue . Binding cisplatin proteins enzyme generally believe cause several severe side effect exhibit drug , especially ototoxicity nephrotoxicity . Despite numerous study platinum-protein bind last decade , roles platinum-protein adduct drug action , toxicity drug know . Although cisplatin-protein adduct widely believe cause drug 's side effect , also claim platinum-protein adduct important drug 's activity . Therefore , good understand molecular mechanism platinum-protein interaction may impact optimization strategy platinum treatment . It important understand basic principle govern formation reactivity platinum-protein adduct adduct may important define therapeutic profile drug . In quest , first goal develop reliable technique study . To date , ultraviolet/visible ( UV-Vis ) , fourier transform infrared ( FT-IR ) , nuclear magnetic resonance ( NMR ) study cisplatin-protein interaction provide low-resolution information mechanism bind nature adduct . The researcher propose investigate role platinum-protein adduct mechanisms drug action contribution towards toxicity drug . The short-term objective investigate platinum interaction serum proteins use nanoelectrospray mass spectrometry ( nanoESI-MS ) combination size exclusion high performance liquid chromatography inductively couple plasma mass spectrometry ( HPLC/ICP-MS ) . The long-term objective research develop biomarkers base platinum-protein adduct clinical monitoring . Initially , metallothionein human hemoglobin use model protein develop nESI/MS HPLC/ICP-MS technique study cisplatin-protein interaction vitro . The researcher demonstrate combination size exclusion HPLC/ICP-MS nanoESI/MS provide new information adduct formation potential reaction mechanism . The size exclusion HPLC ICP-MS enable monitor cisplatin-protein binding physiological condition . Nanospray tandem MS offer information formation specific complex characteristic bind . This information useful well understanding drug toxicity treatment resistance . The information platinum-protein interaction allow u evaluate utility nanoESI/MS size exclusion HPLC/ICP-MS technique provide mechanistic , kinetic structural information bind platinum protein . The methodology validate study platinum-blood protein adduct cancer patient undergo chemotherapeutic treatment . The correlation level platinum-protein adduct clinical outcome study . The successful completion research program provide researcher well understanding mechanisms drug action toxicity . This knowledge great importance clinical monitoring cancer patient assist doctor improve cancer chemotherapy .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>To lung colorectal cancer treat either oxaliplatin , carboplatin cisplatin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>platinum analogue</keyword>
	<keyword>cisplatin , carboplatin , oxaliplatin</keyword>
	<keyword>proteomics</keyword>
	<keyword>hemoglobin</keyword>
</DOC>